News
02-24-2020, 06:40 PM
Modern anticancer therapies aim to attack tumor cells while sparing healthy tissue. An interdisciplinary team of researchers at Helmholtz-Zentrum Dresden-Rossendorf and FU Berlin has made important progress in this area: the scientists have produced tiny nanoparticles that are designed to specifically target cancer cells.
More... (https://www.news-medical.net/news/20200224/Guiding-nanoparticles-directly-to-the-tumor-cells.aspx)
More... (https://www.news-medical.net/news/20200224/Guiding-nanoparticles-directly-to-the-tumor-cells.aspx)